Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma

Matthew F. Buas(Roswell Park Comprehensive Cancer Center), Margaret M. Madeleine(Fred Hutch Cancer Center), Nicholas J. Shaheen(University of North Carolina at Chapel Hill), Harvey A. Risch(University of New Haven), Puya Gharahkhani(Queensland University of Technology), Thomas L. Vaughan(Fred Hutch Cancer Center), Marilie D. Gammon(Columbia University), Lynn Onstad(Fred Hutch Cancer Center), Laura J. Hardie(University of Leeds), David C. Whiteman(Queensland Health), John de Caestecker(University Hospitals of Leicester NHS Trust), Qianchuan He(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Rebecca Harrison(University Hospitals of Leicester NHS Trust), Stuart MacGregor(The University of Queensland), Aaron P. Thrift, Douglas A. Corley(Kaiser Permanente), Ian Tomlinson(University of Oxford), Jesper Lagergren(Karolinska University Hospital), Leslie Bernstein(National Cancer Institute), Prassad Iyer(Mayo Clinic), Rebecca C. Fitzgerald(Cancer Research UK), Sharon Love(Nuffield Orthopaedic Centre), Laura Chegwidden, Paul Moayyedi(McMaster University Medical Centre), Hans Prenen(Antwerp University Hospital), Lisa Johnson(Fred Hutch Cancer Center), Peter J. Watson(Kinston Medical Specialists), Anna H. Wu(University of Southern California), David MacDonald(University of British Columbia Hospital), Wong‐Ho Chow(Chi Mei Medical Center), David Levine(University of Washington), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Carlos Caldas(University of Cambridge), Janusz Jankowski(University College London), Weimin Ye(Fujian Medical University), Geoffrey Liu(Princess Margaret Cancer Centre), Stephen E. Attwood(Durham University), Hugh Barr(Gloucestershire Hospitals NHS Foundation Trust), Nigel C. Bird(University of Sheffield), Claire Palles(University of Oxford)
Cited by 50


Related Papers